Stephen K. Tyring, MD, PhD
March/April 2013—A majority of individuals age 50 or older could potentially avoid shingles or post-herpetic neuralgia.
Zac Haughn, Senior Associate Editor
January/February 2013—Investigational drug studies are being hyped with promising results in dementia. Can the therapies live up to lofty expectations?
Q&A WITH JACINTA JOHNSON, B.Pharm
January/February 2013—New evidence suggests that opioid overuse headache may involve activation of glial cells, in particular astrocytes and microglia, which creates a pro-inflammatory state that leads to pain facilitation.
Joseph Jankovic, MD
November/December 2012—Healthcare professionals don’t always recognize the many differences in the presentation, course, and treatment of ET and PD.
Mark Kaufmann, MD
November/December 2012—As practices move toward EHRs, practical issues like system security and fraud (willful or accidental) warrant consideration.
Zac Haughn, Senior Associate Editor
September/October 2012—New advancements suggest enhanced opportunities to improve outcomes and save lives. Experts weigh in.
